Retraction to: Prevention of nausea and vomiting after middle ear surgery: Granisetron versus ramosetron (The Laryngoscope, (1999), 109, (1988–1990), 10.1097/00005537-199912000-00017);Prevention of nausea and vomiting after middle ear surgery: Granisetron versus ramosetron

Laryngoscope

Volumn 109, Issue 12, 1999, Pages 1988-1990

  Fujii, Yoshitaka ^a,b   Tanaka, Hiroyoshi ^a   Kobayashi, Noriaki ^a  

^a Toride Kyodo General Hospital   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Antiemetics; Granisetron; Middle ear surgery; Ramosetron; Vomiting

Indexed keywords

GRANISETRON; RAMOSETRON;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MIDDLE EAR SURGERY; NAUSEA; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VOMITING;

EID: 0032706485     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.26509     Document Type: Erratum

References (13)

1. Honkavaara P, Saarinvaara L, Klemola U-K. Prevention of nausea and vomiting with transdermal hyoscine in adults after middle ear surgery during general anaesthesia. Br J Anaesth 1994;73:763-766.
2. Honkavaara P. Effect of ondansetron on nausea and vomiting after middle ear surgery during general anaesthesia. Br J Anaesth 1996;76:316-318.
3. Reinhart DJ, Klein KW, Schroff E. Transdermal scopolamine for the reduction of postoperative nausea in outpatient ear surgery: a double-blind, randomized study. Anesth Analg 1994;79:281-284.
4. Watcha MF, White PF. Postoperative nausea and vomiting. Its etiology, treatment, and prevention. Anesthesiology 1992;77:162-184.
5. Fujii Y, Toyooka H, Tanaka H. Granisetron reduces the incidence of nausea and vomiting following middle ear surgery. Br J Anaesth 1997;79:539-540.
6. Fujii Y, Toyooka H, Tanaka H. Granisetron in the prevention of nausea and vomiting after middle-ear surgery: a dose-ranging study. Br J Anaesth 1998;80:764-766.
7. Fujii Y, Toyooka H, Tanaka H. Prophylactic anti-emetic therapy with granisetron, droperidol and metoclopramide in female patients undergoing middle ear surgery. Anaesthesia 1998;53:1165-1168.
8. 3 receptor antagonistic and antiemetic effect in the ferret. Lab Clin 1996;30:1965-1972.
9. 3 receptor antagonist BRL 43694. Br J Cancer 1988;58:644-650.
10. 3 receptor antagonist: correlation of anti-emetic response. Cancer Chemother Pharmacol 1989;24:45-49.
11. Noda K, Ikeda M, Yoshida O, Taguchi T, Shimoyama T, Nakajima M. Clinical evaluation of ramosetron against the nausea and vomiting induced by anticancer drugs. Jpn J Clin Exp Med 1994;71:2765-2776.
12. Aspinall RL, Goodman NW. Denial of effective treatment and poor quality of clinical information in placebo controlled trials of ondansetron for postoperative nausea and vomiting: a review of published trials. BMJ 1995;311:844-846.
13. Yarker YE, McTavish D. Granisetron. An update of its therapeutic use in nausea and vomiting induced by antineo-plastic therapy. Drugs 1994;48:761-793.